Trial intelligence / Profile preview

Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy

NCT05121168Phase 4Completed

Sponsor
University of California, San Diego
Start
Mar 2022
Primary completion
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial of bupivacaine in acute postoperative pain (2 arms), sponsored by University of California, San Diego. Primary endpoints: Mean of the 'Average' Pain at Rest on Postoperative Days 1 and 2 at Day 2 and Total Opioid Consumption From Recovery Room Discharge Until Postoperative Day 2. Started Mar 2022; status: completed.

02

Drugs

bupivacaine
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on NCT05121168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05121168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call